InvestorsHub Logo
Followers 241
Posts 12376
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Sunday, 04/05/2020 4:12:50 PM

Sunday, April 05, 2020 4:12:50 PM

Post# of 249
Any thoughts on the company moving off the grey market. I believe the share price would meet OTC requirements, but I'm unsure if they meet all such requirements. While they probably could go on the Pinks as well, I'm of the belief that it's hardly better than the grey market. The OTC should be the next step, and when the price meets requirements for other exchanges the move to one of those exchanges. By the way, most people think of the Nasdaq, but I believe the AMEX only requires a $1 price is a reasonable step up that could be achieved far quicker with no consideration of a reverse split which I would hate to see.

In reality, if our vaccine truly proved effective for coronavirus, and was in some way determined superior to others in development, a price in excess of $4 could come quickly as well. I suspect such a determination would result in either a partnership for it's development, or a buyout of either the entire company, or the product.

I certainly agree with all who find that getting information about the company is rather like pulling teeth, but many biotechs are no different. The grey market might limit it a little more, but the fact that it's listed in Canada should provide roughly the same information as what's required by our SEC.

Gary

Gary